IOWH032 - CAS 1191252-49-9
Catalog number: 1191252-49-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
iOWH-032 is a novel and potent CFTR inhibitor (IC50=1.01 uM) in T84 and CHO-CFTR cell based assays.
Publictions citing BOC Sciences Products
  • >> More
white to off-white solid powder
iOWH-032; IOWH032; IOWH 032
1.Developing novel antisecretory drugs to treat infectious diarrhea.
de Hostos EL1, Choy RK, Nguyen T. Future Med Chem. 2011 Aug;3(10):1317-25. doi: 10.4155/fmc.11.87.
Diarrhea, a disease of poverty and poor sanitation, kills an estimated two million children each year. Oral rehydration therapy is a very simple and inexpensive treatment that has significantly reduced mortality from secretory diarrhea caused by rotavirus, cholera and enterotoxigenic Escherichia coli. The efficacy and adoption of oral rehydration therapy would be enhanced by a drug that reduces fluid loss associated with these diseases and alleviates disease symptoms. Secretion and absorption by the intestine offer a number of potential drug targets to reduce fluid loss. Among these, the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel is the most attractive because it is the primary driver of secretion in cases of diarrhea caused by enterotoxigenic bacteria. CFTR can be inhibited by both natural products and synthetic small molecules. iOWH032 is a synthetic CFTR inhibitor that has recently entered clinical trials for this indication.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related CFTR Products

CAS 775304-57-9 Ataluren

(CAS: 775304-57-9)

Ataluren is an investigational new drug designed to enable the formation of a functioning protein in patients with genetic disorders due to a nonsense mutation....

CAS 873054-44-5 Ivacaftor

(CAS: 873054-44-5)

Ivacaftor is a potentiator of CFTR targeting G551D-CFTR(EC50=100 nM)and F508del-CFTR(EC50=25 nM).

CAS 1134822-09-5 Ivacaftor benzenesulfonate

Ivacaftor benzenesulfonate
(CAS: 1134822-09-5)

Ivacaftor benzenesulfonate is a potentiator of CFTR targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM, respectively.

CAS 1191252-49-9 IOWH032

(CAS: 1191252-49-9)

iOWH-032 is a novel and potent CFTR inhibitor (IC50=1.01 uM) in T84 and CHO-CFTR cell based assays.

CAS 307510-92-5 CFTRinh-172

(CAS: 307510-92-5)

CFTRinh-172 is a voltage-independent, selective CFTR inhibitor with Ki of 300 nM, showing no effects on MDR1, ATP-sensitive K+ channels, or a series of other tr...

CAS 1314873-02-3 BPO-27 racemate

BPO-27 racemate
(CAS: 1314873-02-3)

BPO-27 racemate inhibited CFTR with IC50 ≈ 8 nM and had greatly improved in vitro metabolic stability and aqueous solubility compared to PPQ-102.

CAS 931706-15-9 PPQ-102

(CAS: 931706-15-9)

CAS 1415390-47-4 (R)-BPO-27

(CAS: 1415390-47-4)

(R)-BPO-27, the benzopyrimido-pyrrolo-oxazinedione, is a potent CFTR inhibitor (IC50= 4 nM) with low-nanomolar potency.

CAS 1134822-07-3 Ivacaftor hydrate

Ivacaftor hydrate
(CAS: 1134822-07-3)

Ivacaftor hydrate is a potentiator of CFTR targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM, respectively.

CAS 1152311-62-0 VX-661

(CAS: 1152311-62-0)

VX-661 is a second F508del CFTR corrector and is believed to help CFTR protein reach the cell surface. Phase 2.

CAS 774549-97-2 KM11060

(CAS: 774549-97-2)

KM11060 is a mutated F508del cystic fibrosis transmembrane conductance regulator (CFTR) corrector. KM11060 is an analog of sildenafil, which restores a function...

CAS 936727-05-8 Lumacaftor

(CAS: 936727-05-8)

VX-809 is the second investigational oral candidate compound for the treatment of cystic fibrosis (CF). VX-809 may act to restore the function of the cystic fib...

CAS 328541-79-3 GlyH-101

(CAS: 328541-79-3)

N-2-Naphthalenyl-glycine 2-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene]hydrazide is a glycine hydrazide that has recently been shown to block CFTR channels. How...

Chemical Structure

CAS 1191252-49-9 IOWH032

Quick Inquiry

Verification code

Featured Items